Bearish flow noted in Iovance Biotherapeutics with 1,107 puts trading, or 2x expected. Most active are Jul-24 8 puts and Jan-25 9 calls, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 1.81, while ATM IV is up over 14 points on the day. Earnings are expected on August 6th.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics submits MAA to EMA for lifileucel
- Jefferies healthcare analyst holds an analyst/industry conference call
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)